Announce Date | 08/05/2025 |
EPS Normalized Actual | $0.1 In Line |
EPS GAAP Actual | $0.1 In Line |
Revenue Actual | $0.528B |
Revenue Surprise | Beat by $528M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.16716 |
EPS GAAP Estimate | $0.16716 |
Revenue Estimate | $0.85888607B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | 0.28401 | 12.89 | 0.28002 | 0.28815 | 1 |
Dec 2025 | 0.39 | 9.38 | 0.39 | 0.39 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -2.03 | -2.03 | 0.528B | -1.89% | 528M |
FQ1 2025 (Mar 2025) | -0.05 | -0.05 | 0.548B | -2.01% | 548M |
FQ4 2024 (Dec 2024) | 0.0531 | 0.0531 | 0.68B | -41.18% | 680M |
FQ3 2024 (Sep 2024) | -0.14 | -0.14 | 0.555B | -46.49% | 555M |
FQ4 2017 (Dec 2017) | 481.73 | 481.73 | 0.654B | 100% | 654M |
FQ4 2018 (Dec 2018) | 143.36 | 143.36 | 0.651B | -0.46% | 651M |
FQ1 2020 (Mar 2020) | -170.5 | -170.5 | 0.693B | 100% | 693M |
FQ2 2024 (Jun 2024) | 0 | 0 | 0.538B | -49.81% | 538M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.16716
Consensus Revenue Estimates
0.85888607B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.28774 | -- | 0.28376 | 0.29586 | 1 |
FQ3 2027 (Sep 2027) | 0.14461 | -- | 0.14329 | 0.14559 | 1 |
FQ2 2027 (Jun 2027) | 0.14251 | -- | 0.14121 | 0.14348 | 1 |
FQ1 2027 (Mar 2027) | 0.13757 | -- | 0.13567 | 0.14145 | 1 |
FQ4 2026 (Oct 2026) | 0.19031 | -- | 0.18508 | 0.19712 | 1 |
FQ3 2026 (Jul 2026) | 0.18213 | -- | 0.17713 | 0.18864 | 1 |
FQ2 2026 (Jun 2026) | 0.17463 | 1262.46 | 0.17133 | 0.17725 | 1 |
FQ1 2026 (Mar 2026) | 0.17216 | 129.04 | 0.1689 | 0.17475 | 1 |
FQ4 2025 (Oct 2025) | 0.18362 | 71.08 | 0.17858 | 0.19019 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.73B | -- | 0.72B | 0.75B | 2 |
FQ3 2027 (Sep 2027) | 0.62B | -- | 0.61B | 0.62B | 2 |
FQ2 2027 (Jun 2027) | 0.58B | -- | 0.57B | 0.58B | 2 |
FQ1 2027 (Mar 2027) | 0.58B | -- | 0.58B | 0.59B | 2 |
FQ4 2026 (Oct 2026) | 0.9B | -- | 0.88B | 0.92B | 2 |
FQ3 2026 (Jul 2026) | 0.9B | -- | 0.88B | 0.92B | 2 |
FQ2 2026 (Jun 2026) | 0.95B | 44.45 | 0.94B | 0.96B | 4 |
FQ1 2026 (Mar 2026) | 0.97B | 43.76 | 0.96B | 0.99B | 4 |
FQ4 2025 (Oct 2025) | 0.91B | 25.08 | 0.89B | 0.93B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | -2.03 | -2.03 | 100% | |
FQ1 2025 (Mar 2025) | -0.05 | -0.05 | 100% | |
FQ4 2024 (Dec 2024) | 0.0531 | 0.0531 | 100% | |
FQ3 2024 (Sep 2024) | -0.14 | -0.14 | 100% | |
FQ4 2017 (Dec 2017) | 481.73 | 481.73 | 100% | |
FQ4 2018 (Dec 2018) | 143.36 | 143.36 | 100% | |
FQ1 2020 (Mar 2020) | -170.5 | -170.5 | 100% | |
FQ2 2024 (Jun 2024) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $0.53B | $528M | 100% |
FQ1 2025 (Mar 2025) | $0B | $0.55B | $548M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.68B | $680M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.56B | $555M | 100% |
FQ4 2017 (Dec 2017) | $0B | $0.65B | $654M | 100% |
FQ4 2018 (Dec 2018) | $0B | $0.65B | $651M | 100% |
FQ1 2020 (Mar 2020) | $0B | $0.69B | $693M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.54B | $538M | 100% |